Tag.bio sells Software as a Service (SaaS) to interactively analyze healthcare and life sciences data. The company’s proprietary platform—which includes a data mesh architecture, extensible analytical pipelines, and a collaborative, interactive interface—connects disparate sources of data together to enable medical experts, IT organizations, and data scientists to analyze their own data.